Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 8 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

14%

1 of 7 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A

5(62.5%)

Phase 2

2(25.0%)

Phase 1

1(12.5%)

8Total

N/A(5)

Phase 2(2)

Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT06037382Not ApplicableCompleted

Using a Smartphone App to Target Current Mental Health Symptoms of Anxiety and Depression

Role: collaborator

NCT03747302Not ApplicableCompleted

HPV Message Testing and Social Media Campaign

Role: collaborator

NCT03805737Not ApplicableCompleted

Indoor Daylight Photo Dynamic Therapy for Actinic Keratosis

Role: collaborator

NCT02612389Not ApplicableCompleted

Meditative Movement for COPD Symptoms in Non-Smoking Flight Attendants

Role: collaborator

NCT03162718Not ApplicableCompleted

A Feasibility Study of Unsupervised, Pre-operative Exercise Program for Patients Scheduled for Lung Cancer Surgery

Role: collaborator

NCT00970905Phase 2Completed

Effectiveness of Aprepitant in Addition to Ondansetron in the Prevention of Nausea and Vomiting Caused by Upper Abdominal Radiotherapy

Role: collaborator

NCT02117336Phase 1Suspended

Clinical Study of Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)

Role: collaborator

NCT00080743Phase 2Completed

Gefitinib With or Without Tamoxifen in Treating Patients With Tamoxifen-Resistant Metastatic Breast Cancer

Role: collaborator

All 8 trials loaded